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PROSTATE CANCER IN A YOUNG ADULT : A CASE REPORT
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The Department of Urology, Kinki University School of Medicine
We report a case of prostate cancer in a 41-year-old male. The patient initially visited another
institution with a chief complaint of left breech pain. He was referred to our hospital for further
investigation. Serum level of PSA was 267ng/ml and multiple bone metastases were found on bone
scintigram. Digital rectal examination revealed a stony-hard prostate. Computed tomography showed
multiple lung and lymph node metastases. Transperineal needle biopsy of the prostate revealed moderately
differentiated adenocarcinoma (Gleason score 4＋5) from bilateral lobes (the 3th Edition). The patient was
diagnosed with cT4N1M1c prostate cancer and maximal androgen blockade therapy was commenced.
(Hinyokika Kiyo 57 : 585-588, 2011)














現病歴 : 約 1年前から糖尿病による神経因性膀胱に









入院時検査所見 : 末梢血液 : WBC 10.7×103/μl，
Hb 14.9 g/dl，Plt 46×104/μl．
血液生化学検査 : Alb 4.5 g/dl，BUN 21.0 mg/dl，
CRE 0.81 mg/dl，GOT 19 IU/l，GPT 21 IU/l，LDH
219 IU/l，ALP 1, 297 IU/l，Ca 9. 6 mg/dl，HbA1C
9.5％，PSA 267.1 ng/ml





定重量は 62 g であった．








前立腺針生検 : 2010年 7月，経会陰的に12カ所の系
統的生検を行った．12カ所すべてから moderately＞
poorly differentiated adenocarcinoma が 認 め ら れ，
Gleason score 4＋5 という病理所見であった (Fig. 3a，
3b）．







Fig. 1. a :CT showed multiple lung metastases. b : CT revealed direct invasion of prostate cancer to the bladder.
c : Pelvic CT showed bilateral lymph node metastases.
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Fig. 2. Bone scan revealed multiple bone metastases.




日目で PSA は 33.5 ng/ml まで低下し，治療開始 4カ





















かった．Gleason score をみても GS の記載が明らかな
















Fig. 3. Hitological findings of the prostate needle biopsy. Moderately＞poorly differentiated adenocarcinoma.
a : Gleason score 4. b : Gleason score 5 (HE, ×40).
Table 1. Review of 28 patients aged 45 years or younger with prostate cancer in Japan
No Year Author Age Histology Stage Treatment Prognosis
1 1953 鈴木 16 Undifferentiated D2 RT 7M died
2 1956 Hunata 1 Undifferentiated D2 Unknown 1M died
3 1963 西村 34 Unclassified tumor C Endocrine therapy, RT 2Y8M died
4 1967 岡本 22 Undifferentiated D2 Endocrine therapy, chemotherapy, RT 6M died
5 1969 折笹 23 Undifferentiated D2 Endocrine therapy 6M died
6 1980 Shimada 11 Undifferentiated D2 Chemotherapy 1Y3M died
7 1981 吉峰 39 Adenocarcinoma, unclassified C Endocrine therapy Unknown
8 1982 赤坂 29 Poorly C Prostatectomy, RT, chemotherapy 10M died
9 1982 岡田 35 Undifferentiated C RT, pelvic exenteration, endocrine therapy 8M died
10 1985 篠田 43 Poorly D2 Prostatectomy, endocrine therapy, chemotherapy 6Y5M died
11 1990 荒木 44 Poorly D2 Endocrine therapy, chemotherapy 3Y2M alive
12 1990 山本 30 Undifferentiated D1 Radical cystectomy, chemotherapy 1Y alive
13 1994 岡田 24 Small cell carcinoma C Chemotherapy 5M died
14 1999 尾山 43 Poorly D2 Endocrine therapy, MAB 5M alive
15 2001 橋本 35 Well B2 Endocrine therapy, prostatectomy 3M alive
16 2001 増井 43 Poorly D2 MAB, chemotherapy 8M died
17 2002 Kanto 43 Poorly D2 Endocrine therapy 2Y died
18 2002 Kanto 43 Poorly D2 Endocrine therapy, chemotherapy 3Y10M died
19 2002 Kanto 41 Poorly D2 MAB, chemotherapy 1Y4M alive
20 2004 三輪 39 Moderately D2 MAB 7M alive
21 2004 佐々木 45 Moderately D2 Endocrine therapy 3Y alive
22 2004 佐々木 37 Poorly C2 MAB, RT 10M alive
23 2006 田口 42 Moderately D1 Prostatectomy, endocrine therapy, VATS 13Y alive
24 2006 小田代 41 Well B0 Prostatectomy 8M alive
25 2008 鈴木 45 Moderately B2 Prostatectomy 1Y alive
26 2009 有馬 45 Well B0 Prostatectomy 10M alive
27 2009 有馬 39 Poorly D2 MAB 4M alive
28 2010 自験例 41 Moderately＞poorly D2 MAB 6M alive
undifferentiated : undifferentiated carcinoma, well : well-differentiated adenocarcinoma, moderately : moderately differentiated















おり，Sun らは50歳未満の患者では PSA が 2∼2.5
ng/ml 以上で前立腺生検を推奨し7)，また，Lane ら
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